Related Experiment Video
Updated: May 27, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Serum microRNA expression in pregnancies with preeclampsia
T Gunel1, Y G Zeybek, P Akçakaya
1Department of Molecular Biology and Genetics, Faculty of Science, Istanbul University, Vezneciler, Istanbul, Turkey. gunel@istanbul.edu.tr
Abstract:
Preeclampsia continues to be a mortal disease of pregnant women throughout the world. Recently, geneticists, allied with obstetricians, have opened new frontiers. MicroRNAs (miRNAs) are members of a class of small, noncoding RNA molecules. They are critical posttranscriptional regulators of gene expression. We extracted circulating miRNA from maternal plasma and quantified mir-152 and mir-210. We found up-regulated miR-210 levels as well as down-regulated mir-152 levels in preeclampsia patients.We propose that detection of increased mir-210 levels in maternal serum could be used to improve prediction methods for noninvasive prenatal diagnosis of preeclampsia.
Insights
Preeclampsia, a dangerous pregnancy condition, may be predicted using specific microRNAs (miRNAs). Elevated miR-210 and decreased miR-152 levels in maternal blood offer potential for early, noninvasive prenatal diagnosis.
Area of Science:
- Obstetrics and Gynecology
- Genetics
- Molecular Biology
Background:
- Preeclampsia is a significant global cause of maternal mortality.
- MicroRNAs (miRNAs) are key regulators of gene expression.
- Circulating miRNAs in maternal plasma are emerging biomarkers.
Purpose of the Study:
- To investigate the role of specific miRNAs in preeclampsia.
- To determine if circulating miRNA levels can aid in preeclampsia diagnosis.
Main Methods:
- Extraction of circulating microRNAs from maternal plasma.
- Quantification of miR-152 and miR-210 levels using molecular techniques.
- Comparison of miRNA levels between preeclampsia patients and healthy controls.
Main Results:
- miR-210 levels were significantly upregulated in preeclampsia patients.
- miR-152 levels were significantly downregulated in preeclampsia patients.
- Distinct miRNA profiles were observed in preeclampsia.
Conclusions:
- Circulating miR-210 and miR-152 levels show potential as biomarkers for preeclampsia.
- Detection of elevated miR-210 may improve noninvasive prenatal diagnostic methods.
- Further research is warranted to validate these findings for clinical application.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
Mitral Valve Prolapse III: Nursing Management

